Skip to content
DraconiticResearch
Search Sources API
189,280 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BYFrontiers in genetics

cPRArgentina: a population-specific cPRA calculator incorporating optional ABO compatibility

  • Manuel Quirno Costa1
  • María Belén Balekjian2
  • María Soledad Paulos3
  • María Emilia Bianco3
  1. 1Oxford Transplant Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust , ,
  2. 2Sección Histocompatibilidad, Laboratorio Central, Hospital General de Agudos “Carlos G. Durand” , ,
  3. 3Centro Provincial de Histocompatibilidad, Centro Único Coordinador de Ablación e Implante de La Provincia de Buenos Aires , ,
Read full textPDFDOICite

Abstract

Calculated panel reactive antibody (cPRA) is used to assess the proportion of donors expected to be incompatible with a transplant candidate based on unacceptable Human Leukocyte Antigen (HLA) specificities. Its accuracy depends on how well the reference donor population reflects the actual donor pool and on the compatibility criteria considered. We developed cPRArgentina, a web-based application that directly compares patient-specific unacceptable HLA antigens with deceased donor data from Argentina and can optionally incorporate ABO compatibility. We evaluated the application using 100 synthetic recipient profiles covering different levels of HLA sensitization and all ABO blood groups. Incorporating ABO compatibility increased cPRA in all blood groups except AB, with the greatest increases observed in groups O and B. Its effect was also greater among profiles with lower HLA-only cPRA and decreased as HLA sensitization increased. These findings show how incorporating ABO compatibility can change the picture of donor availability beyond HLA sensitization alone. cPRArgentina provides a population-specific approach to cPRA calculation using Argentine donor data, with a flexible design that can incorporate broader donor data and additional HLA information as they become available.

Related

  1. The FINRISK cardiovascular risk calculator: Strong predictive performance in a Finnish population
    HM Elonheimo, J Kontto, J Reinikainen +2
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMCEurope PMC
  2. Dynamic analysis and chaos control of an environmental population model incorporating the wind flow in a stochastic and deterministic perspective
    Muhammad Aqib Abbasi, Fehaid Salem Alshammari
    Scientific ReportsPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  3. Toward Population-Level Brain AVM Screening: Construction and Evaluation of a Two-Step Genetic Risk Model Incorporating Rare Mendelian Variants and a Novel Polygenic Risk Score
    P. D. Patel, S. R. Salwi, M. R. Gooch +6
    medRxivPreprintCC BY-NC-NDFull textHuman geneticsmedRxiv
  4. Sex-specific health phenotypes in a large qatari cohort: a cross-sectional analysis with implications for population health policy
    Aisha Al-Khinji, Muna Rayashi, Dhafer Malouche
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  5. Wrist-worn accelerometer-derived activity fragmentation and cause-specific mortality in US adults: a population-based prospective cohort study
    Jie Li, Xiubo Sun, Jing Zhang +2
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0PhysiologyCrossref

Cite

BibTeXRIS
BibTeX
@article{costa2026cprargentina,
  title = {{cPRArgentina: a population-specific cPRA calculator incorporating optional ABO compatibility}},
  author = {Manuel Quirno Costa and María Belén Balekjian and María Soledad Paulos and María Emilia Bianco},
  journal = {Frontiers in genetics},
  year = {2026},
  month = oct,
  doi = {10.3389/fgene.2026.1971911},
  url = {https://europepmc.org/article/PMC/PMC13724353},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - cPRArgentina: a population-specific cPRA calculator incorporating optional ABO compatibility
AU  - Manuel Quirno Costa
AU  - María Belén Balekjian
AU  - María Soledad Paulos
AU  - María Emilia Bianco
PY  - 2026
DA  - 2026/10/19
JO  - Frontiers in genetics
DO  - 10.3389/fgene.2026.1971911
UR  - https://europepmc.org/article/PMC/PMC13724353
AB  - Calculated panel reactive antibody (cPRA) is used to assess the proportion of donors expected to be incompatible with a transplant candidate based on unacceptable Human Leukocyte Antigen (HLA) specificities. Its accuracy depends on how well the reference donor population reflects the actual donor pool and on the compatibility criteria considered. We developed cPRArgentina, a web-based application that directly compares patient-specific unacceptable HLA antigens with deceased donor data from Argentina and can optionally incorporate ABO compatibility. We evaluated the application using 100 synthetic recipient profiles covering different levels of HLA sensitization and all ABO blood groups. Incorporating ABO compatibility increased cPRA in all blood groups except AB, with the greatest increases observed in groups O and B. Its effect was also greater among profiles with lower HLA-only cPRA and decreased as HLA sensitization increased. These findings show how incorporating ABO compatibility can change the picture of donor availability beyond HLA sensitization alone. cPRArgentina provides a population-specific approach to cPRA calculation using Argentine donor data, with a flexible design that can incorporate broader donor data and additional HLA information as they become available.
SN  - 1664-8021
ER  -